Developing assays for kinase drug discovery – where have the advances come from?

Bibliography

• Inglese J, Johnson RL, Simeonov A, et al. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 2007;3(8):466-79
   PubMed Web of Science ®Google Scholar
• Fischer E, Krebs E. Conversion of phosphorylase b to phosphorylase A in mucle extracts. J Biol Chem 1955;216:121-32
   PubMed Web of Science ®Google Scholar
• Knighton DR, Zheng JH, Ten Eyck LF, et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991;253(5018):407-14
   PubMed Web of Science ®Google Scholar
• Knighton DR, Zheng JH, Ten Eyck LF, et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991;253(5018):414-20
   PubMed Web of Science ®Google Scholar
• Johnson LN, Noble ME, Owen DJ. Active and inactive protein kinases: structural basis for regulation. Cell 1996;85(2):149-58
   PubMed Web of Science ®Google Scholar
• Huse M, Kuriyan J. The conformational plasticity of protein kinases. Cell 2002;109(3):275-82
   PubMed Web of Science ®Google Scholar
• Nolen B, Taylor S, Ghosh G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 2004;15(5):661-75
   PubMed Web of Science ®Google Scholar
• Johnson LN, Lewis RJ. Structural basis for control by phosphorylation. Chem Rev 2001;101(8):2209-42
   PubMed Web of Science ®Google Scholar
• Adams JA. Kinetic and catalytic mechanisms of protein kinases. Chem Rev 2001;101(8):2271-90
   PubMed Web of Science ®Google Scholar
• Hubbard SR, Wei L, Ellis L, Hendrickson WA. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994;372(6508):746-54
   PubMed Web of Science ®Google Scholar
• Schindler T, Bornmann W, Pellicena P, et al. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 2000;289(5486):1938-42
   PubMed Web of Science ®Google Scholar
• Liu Y, Gray NS. Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol 2006;2(7):358-64
   PubMed Web of Science ®Google Scholar
• Mol CD, Fabbro D, Hosfield DJ. Structural insights into the conformational selectivity of STI-571 and related kinase inhibitors. Curr Opin Drug Discov Dev 2004;7(5):639-48
   PubMed Web of Science ®Google Scholar
• Okram B, Nagle A, Adrian FJ, et al. A general strategy for creating “inactive-conformation” abl inhibitors. Chem Biol 2006;13(7):779-86
   PubMed Web of Science ®Google Scholar
• Pargellis C, Tong L, Churchill L, et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol 2002;9(4):268-72
   PubMedGoogle Scholar
• Rodems SM, Hamman BD, Lin C, et al. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. Assay Drug Dev Technol 2002;1(1 Pt 1):9-19
   PubMed Web of Science ®Google Scholar
• Zaman GJ, van der Lee MM, Kok JJ, et al. Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors. Assay Drug Dev Technol 2006;4(4):411-20
   PubMed Web of Science ®Google Scholar
• Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351(Pt 1):95-105
   PubMed Web of Science ®Google Scholar
• Bhatnagar D, Roskoski R Jr, Rosendahl MS, Leonard NJ. Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: a new fluorescence displacement titration technique for characterizing the nucleotide binding site on the catalytic subunit. Biochemistry 1983;22(26):6310-17
   PubMed Web of Science ®Google Scholar
• Zhang WX, Wang R, Wisniewski D, et al. Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase. Anal Biochem 2005;343(1):76-83
   PubMed Web of Science ®Google Scholar
• Kashem MA, Nelson RM, Yingling JD, et al. Three mechanistically distinct kinase assays compared: measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. J Biomol Screen 2007;12(1):70-83
   PubMed Web of Science ®Google Scholar
• Peterson MF, Martin WH, Spencer RW, Tate BF. The use of beta, gamma-methyleneadenosine 5′-triphosphate to determine ATP competition in a scintillation proximity kinase assay. Anal Biochem 1999;271(2):131-6
   PubMed Web of Science ®Google Scholar
• Slon-Usakiewicz JJ, Dai JR, Ng W, et al. Global kinase screening. Applications of frontal affinity chromatography coupled to mass spectrometry in drug discovery. Anal Chem 2005;77(5):1268-74
   PubMed Web of Science ®Google Scholar
• Annis DA, Nazef N, Chuang CC, et al. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. J Am Chem Soc 2004;126(47):15495-503
   PubMed Web of Science ®Google Scholar
• Wang WU, Chen C, Lin KH, et al. Label-free detection of small-molecule-protein interactions by using nanowire nanosensors. Proc Natl Acad Sci USA 2005;102(9):3208-12
   PubMed Web of Science ®Google Scholar
• Fabian MA, Biggs WH III, Treiber DK, et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 2005;23(3):329-36
   PubMed Web of Science ®Google Scholar
• Vainshtein I, Silveria S, Kaul P, et al. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP). J Biomol Screen 2002;7(6):507-14
   PubMed Web of Science ®Google Scholar
• Bantscheff M, Eberhard D, Abraham Y, et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol 2007;25(9):1035-44
   PubMed Web of Science ®Google Scholar
• Parker GJ, Law TL, Lenoch FJ, Bolger RE. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J Biomol Screen 2000;5(2):77-88
   PubMed Web of Science ®Google Scholar
• Morgan AG, McCauley TJ, Stanaitis ML, et al. Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination. Assay Drug Dev Technol 2004;2(2):171-81
   PubMed Web of Science ®Google Scholar
• Xia W, Rininsland F, Wittenburg SK, et al. Applications of fluorescent polymer superquenching to high throughput screening assays for protein kinases. Assay Drug Dev Technol 2004;2(2):183-92
   PubMed Web of Science ®Google Scholar
• Loomans EE, van Doornmalen AM, Wat JW, Zaman GJ. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. Assay Drug Dev Technol 2003;1(3):445-53
   PubMed Web of Science ®Google Scholar
• Braun S, Raymond WE, Racker E. Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J Biol Chem 1984;259(4):2051-4
   PubMed Web of Science ®Google Scholar
• Kemp BE, Pearson RB. Protein kinase recognition sequence motifs. Trends Biochem Sci 1990;15(9):342-6
   PubMed Web of Science ®Google Scholar
• Kemp BE, Pearson RB. Design and use of peptide substrates for protein kinases. Methods Enzymol 1991;200:121-34
   PubMed Web of Science ®Google Scholar
• Hibi M, Lin A, Smeal T, et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;7(11):2135-48
   PubMed Web of Science ®Google Scholar
• Kallunki T, Su B, Tsigelny I, et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994;8(24):2996-3007
   PubMed Web of Science ®Google Scholar
• Mooney LM, Whitmarsh AJ. Docking interactions in the c-Jun N-terminal kinase pathway. J Biol Chem 2004;279(12):11843-52
   PubMed Web of Science ®Google Scholar
• Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995;267(5196):389-93
   PubMed Web of Science ®Google Scholar
• Livingstone C, Patel G, Jones N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J 1995;14(8):1785-97
   PubMed Web of Science ®Google Scholar
• Seethala R, Menzel R. A fluorescence polarization competition immunoassay for tyrosine kinases. Anal Biochem 1998;255(2):257-62
   PubMed Web of Science ®Google Scholar
• Jia Y, Quinn CM, Clabbers A, et al. Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization. Anal Biochem 2006;350(2):268-76
   PubMed Web of Science ®Google Scholar
• Osmond RI, Sheehan A, Borowicz R, et al. GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors. J Biomol Screen 2005;10(7):730-7
   PubMed Web of Science ®Google Scholar
• Riddle SM, Vedvik KL, Hanson GT, Vogel KW. Time-resolved fluorescence resonance energy transfer kinase assays using physiological protein substrates: applications of terbium-fluorescein and terbium-green fluorescent protein fluorescence resonance energy transfer pairs. Anal Biochem 2006;356(1):108-16
   PubMed Web of Science ®Google Scholar
• Horton RA, Strachan EA, Vogel KW, Riddle SM. A substrate for deubiquitinating enzymes based on time-resolved fluorescence resonance energy transfer between terbium and yellow fluorescent protein. Anal Biochem 2007;360(1):138-43
   PubMed Web of Science ®Google Scholar
• Robers MB, Horton RA, Bercher MR, et al. High-throughput cellular assays for regulated post-translational modifications. Anal Biochem 2007:In Press. Doi: 10.1016/j.ab.2007.09.012
   PubMedGoogle Scholar
• Charter NW, Kauffman L, Singh R, Eglen RM. A generic, homogenous method for measuring kinase and inhibitor activity via adenosine 5′-diphosphate accumulation. J Biomol Screen 2006;11(4):390-9
   PubMed Web of Science ®Google Scholar
• Chiku T, Pullela PK, Sem DS. A dithio-coupled kinase and ATPase assay. J Biomol Screen 2006;11(7):844-53
   PubMed Web of Science ®Google Scholar
• Shults MD, Imperiali B. Versatile fluorescence probes of protein kinase activity. J Am Chem Soc 2003;125(47):14248-9
   PubMed Web of Science ®Google Scholar
• Johnston PA, Johnston PA. Cellular platforms for HTS: three case studies. Drug Discov Today 2002;7(6):353-63
   PubMed Web of Science ®Google Scholar
• Zlokarnik G, Negulescu PA, Knapp TE, et al. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 1998;279(5347):84-8
   PubMed Web of Science ®Google Scholar
• Xing H, Tran HC, Knapp TE, et al. A fluorescent reporter assay for the detection of ligands acting through Gi protein-coupled receptors. J Recept Signal Transduct Res 2000;20(4):189-210
   PubMed Web of Science ®Google Scholar
• Sharif TR, Sharif M. A novel approach for examining the anti-proliferative effect of protein kinase C inhibitors against human astrocytoma cells. Int J Oncol 1998;13(4):685-92
   PubMed Web of Science ®Google Scholar
• O'Grady M, Raha D, Hanson BJ, et al. Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer. BMC Cancer 2005;5:125
   PubMedGoogle Scholar
• Chin J, Adams AD, Bouffard A, et al. Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors. Assay Drug Dev Technol 2003;1(6):777-87
   PubMed Web of Science ®Google Scholar
• Cunningham ME, Kapitskaya M, Petrukhin K, Bednar B. Preparation and characterization of calibration beads for sorting cells expressing a beta-lactamase gene reporter. Cytometry A 2005;65(2):133-9
   PubMedGoogle Scholar
• Kunapuli P, Ransom R, Murphy KL, et al. Development of an intact cell reporter gene beta-lactamase assay for G protein-coupled receptors for high-throughput screening. Anal Biochem 2003;314(1):16-29
   PubMed Web of Science ®Google Scholar
• Peekhaus NT, Ferrer M, Chang T, et al. A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format. Assay Drug Dev Technol 2003;1(6):789-800
   PubMed Web of Science ®Google Scholar
• Zuck P, Murray EM, Stec E, et al. A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication. Anal Biochem 2004;334(2):344-55
   PubMed Web of Science ®Google Scholar
• Ruocco KM, Goncharova EI, Young MR, et al. A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1. J Biomol Screen 2007;12(1):133-9
   PubMed Web of Science ®Google Scholar
• Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998;9(5):457-63
   PubMed Web of Science ®Google Scholar
• Hellweg CE, Baumstark-Khan C, Horneck G. Generation of stably transfected Mammalian cell lines as fluorescent screening assay for NF-kappaB activation-dependent gene expression. J Biomol Screen 2003;8(5):511-21
   PubMed Web of Science ®Google Scholar
• Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352(17):1779-90
   PubMed Web of Science ®Google Scholar
• Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005;106(6):2162-8
   PubMed Web of Science ®Google Scholar
• Fields S, Song O. A novel genetic system to detect protein–protein interactions. Nature 1989;340(6230):245-6
   PubMed Web of Science ®Google Scholar
• Rossi F, Charlton CA, Blau HM. Monitoring protein–protein interactions in intact eukaryotic cells by beta–galactosidase complementation. Proc Natl Acad Sci USA 1997;94(16):8405-10
   PubMed Web of Science ®Google Scholar
• Leveson-Gower DB, Michnick SW, Ling V. Detection of TAP family dimerizations by an in vivo assay in mammalian cells. Biochemistry 2004;43(44):14257-64
   PubMed Web of Science ®Google Scholar
• Fung P, Peng K, Kobel P, et al. A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation. Assay Drug Dev Technol 2006;4(3):263-72
   PubMed Web of Science ®Google Scholar
• Cabantous S, Terwilliger TC, Waldo GS. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 2005;23(1):102-7
   PubMed Web of Science ®Google Scholar
• Remy I, Michnick SW. Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. Proc Natl Acad Sci USA 1999;96(10):5394-9
   PubMed Web of Science ®Google Scholar
• MacDonald ML, Lamerdin J, Owens S, et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2006;2(6):329-37
   PubMed Web of Science ®Google Scholar
• Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998;393(6683):382-6
   PubMed Web of Science ®Google Scholar
• Pawson T, Schlessingert J. SH2 and SH3 domains. Curr Biol 1993;3(7):434-42
   PubMed Web of Science ®Google Scholar
• Lee K, Axel R, Strapps W, Barnea G. Method for assaying protein–protein interaction. US Patent 7,049,076. 2006
   Google Scholar
• Barnea G, Strapps W, Herrada G, et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA (Submitted).
   Google Scholar
• Melnick JS, Janes J, Kim S, et al. An efficient rapid system for profiling the cellular activities of molecular libraries. Proc Natl Acad Sci USA 2006;103(9):3153-8.
   PubMed Web of Science ®Google Scholar
• Warmuth M, Kim S, Gu XJ, et al. Ba/F3 cells and their use in kinase drug discovery. Curr Opin Oncol 2007;19(1):55-60.
   PubMed Web of Science ®Google Scholar